Medical experts are warning that a specific type of "bad" cholesterol known as Lipoprotein(a), or Lp(a), remains undetected by stnadard medical screenings. This genetic condition affects approximately 20% of the population and significantly elevates the risk of cardiovascular eevnts like strokes and heart attacks.

Advertisement

The 1-in-5 inheritance pattern that evades standard checks

Lp(a) represents a significant departure from the traditional understanding of cholesterol management. While most cardiovascular health advice focuses on managing LDL—the "bad" cholesterol influenced by weight, smoking, and diet—Lp(a) is a genetic reality that cannot be altered through lfiestyle alone. This distinction places a massive segment of the population at risk without the tools to self-correct through habit.

According to the report, approximately one in five people inherit high levels of this particle, often without any symptoms to alert them to the danger. Because the condition is silent, many individuals are only diagnosed after experiencing a significant cardiovascular event, such as a heart attack or stroke.

The Apo(a) protein that accelerates plaque buildup

The biological mechanism of Lp(a) makes it more aggressive than the more familiar LDL cholesterol . each Lp(a) particle carries an additional protein called apolipoprotein(a), or Apo(a), which allows it to burrow into artery walls. This process triggers inflammation and accelerates the buildup of fatty plaques, which can eventually rupture and cause life-threatening clots.

A 2009 study highlighted the severity of this risk, finding that people with genetic variants causing high Lp(a) levles faced nearly double the risk of cardiovascular disease. Cardiologist Dr. Ravi Assomull explains that this is a distinct issue from standard cholesterol management, noting that "you can't diet or exercise your way out of this."

James Buckley’s diagnosis and the push for NHS testing

High-profile cases, such as Inbetweeners actor James Buckley, have brought visibility to the condition. After a blood test revealed dangerously high Lp(a) levels,Buckley used his platform to discuss his diagnosis and his subsequent lifestyle changes, including reducing alcohol consumption.

The National Health Service (NHS) does not currently include Lp(a) in its routine testing protocols, a fact the report attributes to the relatively recent clarity regarding its role in heart disease.. This lack of screening has sparked a campaign to include Lp(a) testing in standard NHS Health Checks for individuals over the age of 40.

Will the NHS adopt routine testing for those over 40?

While the medical community is pushing for better detection, several uncertainties remain regarding treatment and policy. It is not yet clear which specific drugs in the pipeline will prove most effective, nor is there a confirmed timeline for when these treatments might become available to the public. Additionally, while the report mentions that scientists believe Lp(a) may aid in wound healing, the exact balance between its protective functions and its cardiovascular risks remains a subject of ongoing study.